← Eichor
Study identifier: NCT07251309 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

A Two-Part, Phase 3 Study Evaluating the Efficacy and Safety of WS016 for the Treatment of Hyperkalemia

Condition: Hyperkalemia  ·  Sponsor: Waterstone Pharmaceutical (Wuhan) Co., LTD.

PhasePhase 3
Planned participants420
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

This clinical trial consists of 2 parts, Part A and Part B. Part A consists of a 2-day randomized, double-blind, placebo-controlled corrective phase (CP) and a 28-day randomized, double-blind, placebo-controlled maintenance phase (MP). Part B (open-label extension, OLE) is an open-label, 11-month extension study carried out in participants who come from Part A and meet certain inclusion criteria.

This description comes directly from the study's public registry record.

Talk to the study team

Waterstone Medical Center  ·  +86 27 87531661  ·  mpr2024_waterstone@waterstonepharma.com

Always discuss trial participation with your own doctor first.

Locations (50)

Investigator Site 02Bengbu, Anhui, ChinaRecruiting
Investigator Site 03Wuhu, Anhui, ChinaRecruiting
Investigator Site 48Chongqing, Chongqing Municipality, ChinaRecruiting
Investigator Site 04Xiamen, Fujian, ChinaRecruiting
Investigator Site 05Lanzhou, Gansu, ChinaRecruiting
Investigator Site 07Guangzhou, Guangdong, ChinaRecruiting
Investigator Site 06Zhanjiang, Guangdong, ChinaRecruiting
Investigator Site 08Huizhou, Guangxi, ChinaRecruiting
Investigator Site 09Nanning, Guangxi, ChinaRecruiting
Investigator Site 10Nanning, Guangxi, ChinaRecruiting
Investigator Site 11Guiyang, Guizhou, ChinaRecruiting
Investigator Site 12Haikou, Hainan, ChinaRecruiting

+ 38 more locations — full list on the registry record.

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07251309